MedTrace Logo

GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescence PCR Method)

NCT05668793 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-12-30

No results posted yet for this study

Summary

The goal of this observational study is to test the clinical efficacy of "GNB4 and Riplet gene methylation combined detection kit (fluorescence PCR method)"in hepatocellular carcinoma auxiliary diagnosis. The main questions it aims to answer are:

1. How consistent are the test results of the kit with the clinical reference diagnostic criteria?
2. Sanger sequencing can visually show whether each sample contains methylation sites, so in this clinical trial, the kit results were compared with Sanger sequencing results to analyze the reagent's accuracy in detecting GNB4 and Riplet gene methylation.

Each participant is required to provide no less than 10 ml of blood to complete the kit test.

Conditions

Interventions

DIAGNOSTIC_TEST

GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescent PCR Method)

Blood samples from participants in the group were collected and methylation tests were performed according to the kit instructions.

Sponsors & Collaborators

  • Wuhan University

    collaborator OTHER

  • Wuhan Ammunition Life-tech Co., Ltd

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-31
Primary Completion
2023-10-31
Completion
2023-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05668793 on ClinicalTrials.gov